OrbiMed Capital GP VI LLC
CIK 1682115
Transactions on file
42
Open-market buys
6
Win rate (buys)
100%
6 scored
Avg % since filing (buys)
+286.2%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | 2026-04-21 | PRLD Prelude Therapeutics Inc | Director10% | Buy | 1,126,126 | $5.00M | +10.6% | open → |
| 2026-04-23 | 2026-04-21 | PRLD Prelude Therapeutics Inc | Director10% | Buy | 1,689,189 | $7.50M | +10.6% | open → |
| 2026-04-09 | 2026-04-08 | ACET Adicet Bio, Inc. | 10% | Sale | 40,416 | $263.5K | +31.4% | open → |
| 2026-04-09 | 2026-04-08 | ACET Adicet Bio, Inc. | 10% | Sale | 32,523 | $204.6K | +36.2% | open → |
| 2026-04-09 | 2026-04-07 | ACET Adicet Bio, Inc. | 10% | Sale | 2,400 | $15.3K | +34.3% | open → |
| 2026-04-09 | 2026-04-07 | ACET Adicet Bio, Inc. | 10% | Sale | 29,319 | $191.5K | +31.2% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 68,766 | $3.73M | +41.8% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 10,733 | $584.3K | +41.4% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 106,384 | $5.78M | +41.8% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 26,596 | $1.44M | +41.8% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 136 | $7.5K | +40.0% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 211 | $11.6K | +40.0% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 53 | $2.9K | +40.0% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 9,222 | $498.1K | +42.6% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 14,267 | $770.6K | +42.6% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 3,567 | $192.7K | +42.6% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 603 | $33.2K | +39.9% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 933 | $51.4K | +39.9% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 233 | $12.8K | +39.9% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 42,930 | $2.34M | +41.4% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 27,750 | $1.51M | +41.4% | open → |
| 2025-03-21 | 2025-03-20 | IRON Disc Medicine, Inc. | Director | Sale | 364 | $19.7K | +42.6% | open → |
| 2025-03-21 | 2025-03-20 | IRON Disc Medicine, Inc. | Director | Sale | 1,457 | $78.7K | +42.6% | open → |
| 2025-03-21 | 2025-03-20 | IRON Disc Medicine, Inc. | Director | Sale | 941 | $50.8K | +42.6% | open → |
| 2025-03-21 | 2025-03-19 | IRON Disc Medicine, Inc. | Director | Sale | 5,228 | $282.4K | +42.5% | open → |
| 2025-03-21 | 2025-03-19 | IRON Disc Medicine, Inc. | Director | Sale | 20,911 | $1.13M | +42.5% | open → |
| 2025-03-21 | 2025-03-19 | IRON Disc Medicine, Inc. | Director | Sale | 13,517 | $730.2K | +42.5% | open → |
| 2025-03-21 | 2025-03-21 | IRON Disc Medicine, Inc. | Director | Sale | 1,320 | $71.3K | +42.6% | open → |
| 2025-03-21 | 2025-03-21 | IRON Disc Medicine, Inc. | Director | Sale | 5,279 | $285.1K | +42.6% | open → |
| 2025-03-21 | 2025-03-21 | IRON Disc Medicine, Inc. | Director | Sale | 3,412 | $184.2K | +42.6% | open → |
| 2025-03-26 | 2025-03-24 | IRON Disc Medicine, Inc. | Director | Sale | 1,956 | $105.8K | +42.3% | open → |
| 2025-03-26 | 2025-03-24 | IRON Disc Medicine, Inc. | Director | Sale | 3,026 | $163.7K | +42.3% | open → |
| 2025-03-26 | 2025-03-24 | IRON Disc Medicine, Inc. | Director | Sale | 756 | $40.9K | +42.3% | open → |
| 2025-04-04 | 2025-04-03 | EWTX Edgewise Therapeutics, Inc. | Director10% | Buy | 372,578 | $7.50M | +90.9% | open → |
| 2025-04-04 | 2025-04-03 | EWTX Edgewise Therapeutics, Inc. | Director10% | Buy | 124,193 | $2.50M | +90.9% | open → |
| 2025-04-11 | 2025-04-09 | CMPX Compass Therapeutics, Inc. | Director10% | Sale | 3,571,428 | $5.68M | — | open → |
| 2025-05-16 | 2025-05-14 | NPCE NeuroPace Inc | 10% | Sale | 134,136 | $2.12M | -6.4% | open → |
| 2025-05-16 | 2025-05-14 | NPCE NeuroPace Inc | 10% | Sale | 34,000 | $542.0K | -7.1% | open → |
| 2025-10-10 | 2025-10-08 | ACET Adicet Bio, Inc. | 10% | Buy | 3,500,000 | $3.50M | +757.0% | open → |
| 2025-10-10 | 2025-10-08 | ACET Adicet Bio, Inc. | 10% | Buy | 1,500,000 | $1.50M | +757.0% | open → |
| 2025-07-30 | 2025-07-25 | IKNA ImageneBio, Inc. | Director | Grant | 83,611 | $208.2K | — | open → |
| 2025-08-12 | 2025-08-08 | TSBX Turnstone Biologics Corp. | Director | U | 3,099,265 | — | — | open → |
